A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine
β Scribed by Michael D Young; M.H Rosenthal; Brian Dickson; Wei Du; Willis C Maddrey
- Book ID
- 117430353
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 84 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hepatitis B and its sequelae are a major public health problem. Vaccines have been available for almost 20 years; however the disease still remains a global problem. Many factors contribute to the failure to control hepatitis B, including the limited nature of the vaccination programs i
The successful prevention of infection with hepatitis B virus (HBV) has been achieved by vaccination with purified hepatitis B surface antigen (HBsAg). The ability of a novel synthetic HBV envelope antigen vaccine (Hep B-3, Hepa-geneβ’; Medeva), which contains part of the pre-S1 and the complete pre-